Abstract
Introduction
Radical cystectomy (RC) and urinary diversion by ileal conduit (IC) or ileal orthotopic
neobladder (ONB) is the standard-of-care for surgical treatment of muscle-invasive
bladder cancer. Yet, it is unclear how urinary diversion affects the patient's health-related
quality of life (HRQOL) in the longer-term.
Methods
HRQOL was assessed preoperatively, 3mo postoperatively and then annually until a maximum
follow-up of 48 months using the validated EORTC QLQ-C30- as well as the bladder cancer-specific
FACT-BL- and QLQ-BLM30-questionnaires. A propensity-score matching for the variables
“age,” “ASA-classification,” “cardiovascular co-morbidity,” “sex” as well as “tumor
stage,” and “preoperative physical functioning score” was performed. Hypothetical
predictors for decreased general HRQOL were analyzed using multivariable logistic
regression models.
Results
After propensity-score matching, 246 patients were analyzed. HRQOL assessment revealed
significant differences regarding preoperative QLQ-C30 symptoms which diminished during
the postoperative time course. Similarly, we did not find significant differences
based on bladder cancer-specific FACT-BL and QLQ-BLM HRQOL assessment including body
image (48 months: 29.6.4 [IC] vs. 40.7 [ONB]; P = .733). Regarding general HRQOL, we found increased global health status scores
for ONB throughout the whole observational period without reaching statistical significance
(48 months: 55.0 [IC] vs. 70.1 [ONB]; P = .079). In multivariate analysis, cardiovascular comorbidity was an independent
predictor of impaired HRQOL 24 months (HR 2.20; CI95% 1.02-5.72, P = .044) and 36 months (HR 6.84; CI95% 1.61-29.14, P = .009) postoperatively.
Conclusion
We did not observe significant differences in bladder-specific as well as generic
HRQOL in the longer-term and consequently, the type of urinary diversion was not an
independent predictor of good general HRQOL in a follow-up period of 4 years.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Genitourinary CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
J.A. Witjes (Chair), HM B, R. Cathomas, et al. Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the EAU Annual Congress Milan 2021. Arnhem, The Netherlands: EAU Guidelines Office; 2021.
- Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy?.J Urol. 2004 Jul; 172: 70-75
- Twenty years experience with an ileal orthotopic low pressure bladder substitute–lessons to be learned.J Urol. 2006 Jul; 176: 161-166
- Long-term results of standard procedures in urology: the ileal neobladder.World J Urol. 2006 Aug; 24: 305-314
- Impact of bladder cancer on health-related quality of life.BJU Int. 2018 Apr; 121: 549-557
- Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit.Eur J Surg Oncol. 2016 Mar; 42: 343-360
- Midterm health-related quality of life after radical cystectomy: a propensity score-matched analysis.Eur Urol Focus. 2020 Jul 15; 6: 704-710
- The relationship between type of urinary diversion and quality of life after radical cystectomy: Ileal conduit versus orthotopic bladder.BJUI Compass. 2020; 1: 133-138
- Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study.World J Urol. 2020 Oct 16; 39 (PMID: 33067727): 2525-2530https://doi.org/10.1007/s00345-020-03484-6
- Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: a meta-analysis.Front Oncol. 2020; 10564779
- The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.J Natl Cancer Inst. 1993 Mar 3; 85: 365-376
- Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30.Eur J Cancer. 2001 Jul; 37: 1331-1334
- The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?.BJU Int. 2002 Sep; 90: 386-390
- Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.Support Care Cancer. 2019 Nov; 27: 4189-4198
- Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg. 2004 Aug; 240: 205-213
- A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study.J Urol. 2014 Feb; 191: 335-340
- Prognostic features for objectively defined urinary continence after radical cystectomy and ileal orthotopic neobladder in a contemporary cohort.J Urol. 2017 Jan; 197: 210-215
- Long-term follow-up and oncological outcome of patients undergoing radical cystectomy for bladder cancer following an enhanced recovery after surgery (eras) protocol: results of a large randomized, prospective, single-center study.Urol Int. 2020; 104: 55-61
- Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention.Qual Life Res. 2013 Dec; 22: 2685-2691
- Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.J Clin Oncol. 2001 Feb 1; 19: 666-675
- Is it safe to offer radical cystectomy to patients above 85 years of Age? A long-term follow-up in a single-center institution.Urol Int. 2020; 104: 975-981
- Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion.World J Urol. 2000 Oct; 18: 338-344
- Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model.BJU Int. 2014 May; 113: 726-732
- Postoperative quality of life in patients with ileal neobladder at short-, intermediate- and long-term follow-up.Urol Int. 2016; 97: 54-60
- Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder.ISRN Urol. 2012; 2012342796
- Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy–a quality-of-life based comparison.Ann R Coll Surg Engl. 2009 Oct; 91: 565-569
- Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions.Urology. 2010 Sep; 76: 671-675
Article Info
Publication History
Published online: March 06, 2022
Accepted:
March 2,
2022
Received in revised form:
March 1,
2022
Received:
November 16,
2021
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
